Study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of AMG 145 in healthy Japanese subjects

Sponsor ID

20110121

Clinicaltrials.gov ID

EUCTIS ID

N/A

EudraCT ID

N/A

Study Details

Phase

Phase 1

Product

Evolocumab

Type

Interventional

Masking

N/A

Enrollment

N/A

Additional Study Details

Primary Outcome Measures

Not Available

Secondary Outcome Measures

Not Available

Study Synopsis

Available Language(s): English

Location

Status

Location

Research Site

Cypress, CA, United States, 90630

Status

Recruiting